Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business and education markets, has added a notes feature to its NurseMagic(TM) app. According to the announcement, the company’s proprietary app now enables users, including certified nursing assistants (“CNAs”), licensed practical nurses (“LPNs”), Advanced Practice Registered Nurses-Certified Nurse Practitioners (“APRN-CNPs”) and nursing practioners (“NPs”), to create notes in various formats including subjective, objective, assessment and plan (“SOAP”); problem, intervention, and evaluation (“PIE”); and data, action and response (“DAR”). The new feature speeds up the creation of required patient record documentation. Nursing notes are detailed records of a patient’s condition, treatment and prognosis, which are created by nurses during patient care. According to the announcement, a study showed that nurses spend an estimated 40% of their shifts on documentation, so reducing documentation burden is a high priority for the nursing profession. “We have been encouraged and inspired by nurse influencers like Cynesse and Nurse Tara, who are rapidly bringing awareness of the power of NurseMagic to their communities,” said Amesite CEO Dr. Ann Marie Sastry in the press release. “We are learning at an incredibly fast rate from our users and are seeing nurses use NurseMagic to write nursing notes. Our aim is to have our app available to every nurse, as quickly as possible — to help them advance, reduce their stress and improve their professional performance.”
To view the full press release, visit https://ibn.fm/pNXaO
About Amesite Inc.
Amesite, an education-tech SaaS company, offers its proprietary learning platform and content services to deploy affordable and effective artificial intelligence (“AI”) for white-labeled online learning programs for colleges and universities. The company’s technology platform leverages cutting-edge AI to offer an innovative out-of-the box, AI-powered learning ecosystem, complete with 24/7 learner support, up-to-date content and ready-to-go programs to quickly deploy and generate revenue. With the announcement of NurseMagic(TM), Amesite has entered the business-to-consumer (“B2C”) AI app market. Amesite has also announced its intention to deliver other apps on its infrastructure including a public safety app that offers training and preparedness for active-shooter response. For more information about the company, please visit www.Amesite.io.
NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
